We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
N4 Pharma Plc | LSE:N4P | London | Ordinary Share | GB00BYW8QM32 | ORD 0.4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.80 | 0.75 | 0.85 | 0.80 | 0.80 | 0.80 | 50,000 | 08:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Drug & Proprietary Stores | 0 | -1.03M | -0.0057 | -1.40 | 1.45M |
Date | Subject | Author | Discuss |
---|---|---|---|
31/7/2018 08:56 | Where is Hugh?? DPs comment putting his absence down to him making fortunes day trading made me chuckle!! | eddie_yates | |
30/7/2018 22:37 | Shareholders are feeling disappointed which is understandable, the biggest broker change reasoning for a fledgling company is 9 times out of 10 for fundraising I must admit. I’d say in this instance it’s due to Nigel needing to have a wider degree of options, he needs commitment and backing, not handbrakes and “what ifs”.. Give it time guys, I’m confident we’re in good hands but have also welcomed your cautious stance with the trials situation. Listening and learning everyday. | featherby81 | |
30/7/2018 22:12 | The problem is a further fund raising I suspect. Their financial forecasts have just gone out the window. The reformulation will cost (assuming they bother) and they are suddenly further away from any possible revenue from it, if ever. So sadly because I am a shareholder, IMHO I can't see it going up any time soon unless they pull a rabbit out of the hat from Nuvec. As I said earlier I expect some sort of cobbled together RNS before any fund raisingto try to get the price up. Nobby | nobbygnome | |
30/7/2018 21:57 | The share is that bad it took someone hating it 7 minutes to reply.. classic haha! The haters clearly loading up! | featherby81 | |
30/7/2018 21:53 | Hugh , absent? I didnt notice. Total garbage. | escapetohome | |
30/7/2018 21:46 | Good call Zebbo, the company has seen a delay on ONE product, no failures and no products written off. Nuvec clearly the catalyst to give some confidence gaining strength back to shareholders once news is released. Patience my friend:) | featherby81 | |
30/7/2018 21:35 | A fair punt at this price. Full analysis of results and possible Nuvec update. Still in play for significant rise | zebbo | |
30/7/2018 15:28 | >> shaltay Careful what you say, hugh might combust! Although he is strangely quiet today..... | nobbygnome | |
30/7/2018 14:36 | The share price deserves to go back to 5 cents. Viagra reformation has failed and Nuvec is far from completion. So the share price should sink to the level before the pumping started last November. | shaltay | |
30/7/2018 12:35 | There can be no complaints about where the share price currently is. The poor trial that didn't get to even halfway as impacted confidence not only in Sildenafil but the heavy hitters on the board and also unrelated Nuvec .... confidence is in the company and not individual products. The only thing that can change current mood is some V positive news .. so come on NT, where is it. chop chop. | onedayrodders | |
30/7/2018 11:26 | Surely this is being 'walked down for a big buyer or an institution'..? At least it's presenting hugh with another golden opportunity to make a fortune day trading, which is probably the reason for his lack of commentary on Twitter. | dplewis1 | |
30/7/2018 11:10 | I doubt any fund raise would be for a few weeks at least assuming that is what is going to happen . The new advisors need to get out and 'sell' the company to it's clients. So it really depends what happens to the price between now and then. You have to expect some sort of cobbled together RNS to try to get the price up. | nobbygnome | |
30/7/2018 11:02 | at what price do folk see the fundraise ? is price action saying around 7.50 7.00 ? | aiminghi | |
30/7/2018 10:50 | Maybe a bounce at 5p? | volsung | |
30/7/2018 10:34 | Basically f all has come from Japan to date. Talks, basic intros at best. Red herring if you ask me. Fund raise coming agree. | ih_575893 | |
30/7/2018 09:30 | Totally entertaining reading! I can’t get enough of Wilson being hammered by DP and Nobby!! Keep up the good work chaps | eddie_yates | |
30/7/2018 07:47 | I would not be impressed at all if hugh wilson admitted he was wrong. He cant even spell Astrazeneca correctly. Youve fallen for a fraud. | escapetohome | |
30/7/2018 07:17 | Your scrambling around to try to fit the statement to the facts isn't working hugh..it's all a bit painful to watch. I hadn't noticed until I took another look at your shameful twitter account that even people on there are beginning to pick up on your overconfident language. To your post, "The reality is that we have one of the biggest pharma's in the world working with N4 to make Nuvec a success. AZ is working with us because they think we have a world-beating delivery system' someone responded:"No, they are working with #N4P to see IF they have a viable, perhaps world beating delivery system. If they thought it WAS a world beating system they would have already signed a deal."Funny how you still fail to see what is clear to everyone else. | dplewis1 | |
30/7/2018 07:14 | Uh-oh! Another fund raising coming? I have seen it so often when companies change advisors..... And hugh, you are sounding more than a little desperate to justify your statement which every rational person knows was just plain incorrect. You do realise, we would all be quite impressed if you admit you were wrong! Incidentally I could select a whole series of other quotes from your twitter feed just as laughable...... | nobbygnome | |
29/7/2018 22:51 | ih_575893 From the Nuvec update on March 8th. "The Company's recent trip to Japan was successful in providing useful introductions to potential partners which will be progressed over the coming months" In answer to a previous question. "Nuvec(R) is a nanosilica system which targets the delivery of therapeutics such as RNA, DNA, vaccines and targeted cancer therapies and is being positioned as a potential alternative delivery system to lipid nanoparticles and lipid nanosomes." And from the results. "We have already announced one collaboration for Nuvec(R) and are looking to enter into further agreements with other companies in 2018" These are the words of the company in the form of an RNS When the news drops, all the deramping of late is going to look pretty stupid. That is my last word on the matter for the time being. | hughwilson | |
29/7/2018 22:29 | Lewis, I said that I did not expect them to come away empty-handed from Japan and they didn`t. Nigel could have released news about the talks in an update on his return from Japan which is what I expected him to do. He chose not to, only later admitting to talks progressing. That does not make me wrong in any way as the talks are going ahead, the fact that Nigel chose not to release news of those talks on his return is down to him. | hughwilson | |
29/7/2018 21:50 | How much time has been spent on talks? Please point me in the direction of evidence? | ih_575893 | |
29/7/2018 21:29 | It is abundantly clear to anyone reading that statement exactly what you were referring to - deals. Stop trying to worm out of it, you are wrong yet again. That twitter feed is a rampers handbook and absolutely shameful. You have been found out here and just can't deal with it. | dplewis1 | |
29/7/2018 20:29 | Nobby, I said news from Japan was probable, as it turns out Japan talks were confirmed. We now await the results of those talks. There are no if`s or buts about it. N4 are in discussions with Japanese pharma`s and we are awaiting the results of those talks, so far from being completely wrong, I am very much right. | hughwilson |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions